Corrigendum: Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond

• Xiaoli Wang,
• Xiaoli Wang,
• Guoyi Li,
• Jingkang Guo,
• Zhiping Zhang,
• Shuzhang Zhang,
• Yudan Zhu,
• Jiwei Cheng,
• Lu Yu,
• Yonghua Ji,
• Yonghua Ji,
• Jie Tao,
• Jie Tao

Affiliations

Xiaoli Wang

Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Xiaoli Wang

Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China

Guoyi Li

Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Jingkang Guo

Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China

Zhiping Zhang

Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China

Shuzhang Zhang

Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China

Yudan Zhu

Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Jiwei Cheng

Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Lu Yu

Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Yonghua Ji

Institute of Biomembrane and Biopharmaceutics, Shanghai University, Shanghai, China

Yonghua Ji

Xinhua Translational Institute for Cancer Pain, Shanghai, China

Jie Tao

Department of Neurology and Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Jie Tao

Putuo Clinical Medical School, Anhui Medical University, Shanghai, China